Drug Classification · Questions 1–6
Identify the pharmacological class or categorical label for each drug or receptor. Vocabulary preparation is sufficient to answer every question in this section.
Question 1
Which of the following insulin preparations is classified as a rapid-acting analog?
Correct Answer
B — Insulin lispro
Rationale
Insulin lispro is a rapid-acting analog, along with insulin aspart and insulin glulisine. These preparations carry amino acid substitutions that disrupt hexamer formation and allow faster subcutaneous absorption, with onset within 10 to 15 minutes. Regular insulin is short-acting (onset 30 to 60 minutes). Neutral protamine Hagedorn insulin is intermediate-acting. Insulin glargine is a long-acting basal analog.
Question 2
Which of the following insulin preparations is classified as the only formulation approved for intravenous administration?
Correct Answer
C — Regular insulin
Rationale
Regular insulin is the only insulin preparation classified as safe for intravenous use. It is used for intravenous infusions in the intensive care unit and perioperative setting. Rapid-acting analogs such as lispro, along with glargine and neutral protamine Hagedorn insulin, are administered only by subcutaneous injection.
Question 3
Which of the following insulin preparations is classified as a long-acting basal analog?
Correct Answer
A — Insulin glargine
Rationale
Insulin glargine is a long-acting basal insulin analog designed to provide a flat, peakless background insulin level. Neutral protamine Hagedorn insulin is intermediate-acting. Insulin lispro is a rapid-acting analog. Regular insulin is short-acting.
Question 4
Which of the following insulin preparations is classified as an ultra-long-acting basal analog with a duration of action that exceeds that of insulin glargine?
Correct Answer
D — Insulin degludec
Rationale
Insulin degludec forms multi-hexamer complexes that dissociate slowly, providing more than 42 hours of coverage — the longest duration of any basal analog currently available. Insulin glargine provides approximately 20 to 24 hours with the standard formulation. Insulin detemir provides 18 to 22 hours, often requiring twice-daily dosing. Neutral protamine Hagedorn insulin is intermediate-acting, with duration of 12 to 18 hours.
Question 5
Which of the following insulin preparations is classified as intermediate-acting?
Correct Answer
A — Neutral protamine Hagedorn insulin
Rationale
Neutral protamine Hagedorn insulin is the only intermediate-acting insulin preparation, with onset of 1 to 2 hours, peak at 4 to 8 hours, and duration of 12 to 18 hours. Insulin aspart is a rapid-acting analog. Insulin detemir and insulin degludec are both long-acting basal analogs.
Question 6
Which of the following insulin preparations is classified as a long-acting basal analog that frequently requires twice-daily dosing?
Correct Answer
C — Insulin detemir
Rationale
Insulin detemir is a long-acting basal analog with a duration of 18 to 22 hours, which is shorter than glargine or degludec and often necessitates twice-daily dosing to maintain adequate overnight coverage. Neutral protamine Hagedorn insulin is intermediate-acting. Insulin glulisine is a rapid-acting analog. Regular insulin is short-acting.
Core Pharmacology · Questions 7–14
Apply your understanding of drug mechanisms, pharmacokinetics, and adverse effects. Each question requires one reasoning step.
Question 7
A patient with type 2 diabetes mellitus is prescribed regular insulin to cover mealtimes. Which of the following best explains why this preparation must be injected approximately 30 minutes before eating, unlike rapid-acting analogs?
Correct Answer
B — Regular insulin forms hexamers in solution that must dissociate into monomers before subcutaneous absorption can occur
Rationale
Regular insulin forms hexamers in the vial. After subcutaneous injection, these hexamers must dissociate into dimers and then monomers before absorption can occur, producing an onset of 30 to 60 minutes. Rapid-acting analogs carry amino acid substitutions that disrupt hexamer formation, allowing much faster absorption with onset within 10 to 15 minutes. Albumin binding is a property of insulin detemir, not regular insulin. Regular insulin does not require enzymatic activation and is not affected by gastric acid.
Question 8
Insulin lispro and insulin aspart act more rapidly after subcutaneous injection than regular insulin. Which of the following best explains this difference in onset?
Correct Answer
D — Amino acid substitutions in rapid-acting analogs disrupt hexamer formation, allowing faster dissociation and absorption
Rationale
Rapid-acting analogs such as lispro, aspart, and glulisine carry specific amino acid substitutions that prevent the normal tendency of insulin to self-associate into hexamers. Because they remain primarily as monomers or dimers in solution, absorption from the subcutaneous depot occurs within 10 to 15 minutes. Receptor potency is the same across all insulin preparations. Concentration differences and lymphatic absorption pathways are not the basis for the pharmacokinetic distinction between preparation classes.
Question 9
Insulin lowers blood glucose in skeletal muscle and adipose tissue primarily by activating a signaling cascade that results in increased glucose uptake. Which of the following best describes the final step in this process that directly increases glucose entry into these cells?
Correct Answer
A — Translocation of glucose transporter type 4 vesicles to the plasma membrane
Rationale
Insulin binds its receptor tyrosine kinase, activating a cascade through insulin receptor substrate proteins and phosphatidylinositol 3-kinase to Akt. In muscle and adipose tissue, activated Akt triggers translocation of glucose transporter type 4 vesicles from intracellular stores to the plasma membrane, dramatically increasing the cell's capacity for glucose uptake. Adenosine triphosphate-sensitive potassium channel closure is part of pancreatic beta cell signaling, not peripheral glucose uptake. Glucokinase and glucose transporter type 2 are primarily hepatic and pancreatic beta cell components.
Question 10
A patient with type 2 diabetes mellitus begins neutral protamine Hagedorn insulin injected at bedtime. Several weeks later, she reports episodes of sweating and confusion that awaken her in the early morning hours. Which of the following best explains the mechanism of this adverse effect?
Correct Answer
C — Neutral protamine Hagedorn insulin has a pronounced peak 4 to 8 hours after injection that coincides with the overnight fasting period
Rationale
Neutral protamine Hagedorn insulin has onset of 1 to 2 hours, a pronounced peak at 4 to 8 hours, and duration of 12 to 18 hours. When injected at bedtime, this peak occurs during the overnight fasting period, when no food intake is present to offset the insulin effect, producing nocturnal hypoglycemia. Long-acting basal analogs such as glargine and degludec are designed to avoid this peak and are preferred for bedtime dosing. The other options do not reflect the pharmacology of neutral protamine Hagedorn insulin.
Question 11
A patient with type 1 diabetes mellitus is treated with insulin and propranolol for hypertension. During a hypoglycemic episode, the patient notices he does not experience his usual warning symptoms of palpitations and tremor, though he is sweating. Which of the following best explains why propranolol blunts these particular warning symptoms?
Correct Answer
B — Propranolol blocks beta-adrenergic receptors, preventing the sympathetic discharge that produces tachycardia and tremor during hypoglycemia
Rationale
Non-selective beta-blockers such as propranolol block the adrenergic neurogenic symptoms of hypoglycemia — tachycardia, palpitations, and tremor — because these symptoms are mediated by sympathetic (adrenergic) activation triggered by falling glucose. Sweating is preserved because it is cholinergic rather than adrenergic and is not blocked by beta-adrenergic antagonists. This masking effect is clinically dangerous because patients may not recognize hypoglycemia until neuroglycopenic symptoms (confusion, loss of consciousness) appear at lower glucose levels.
Question 12
Insulin glargine produces a flat, peakless insulin level over approximately 20 to 24 hours, which distinguishes it from neutral protamine Hagedorn insulin. Which of the following best explains the mechanism responsible for this sustained, peakless release?
Correct Answer
D — Glargine precipitates at the neutral pH of subcutaneous tissue and dissolves slowly, releasing insulin at a constant low rate
Rationale
Insulin glargine is formulated at an acidic pH in the vial. When injected into the neutral pH of subcutaneous tissue, it precipitates into a microprecipitate that dissolves slowly over 20 to 24 hours, producing a flat, peakless absorption profile. Albumin binding is the mechanism of insulin detemir, not glargine. Multi-hexamer complex formation is the mechanism of insulin degludec. Microsphere encapsulation is used by once-weekly exenatide extended-release, not basal insulin analogs.
Question 13
A patient with type 1 diabetes mellitus is found unresponsive at home with a blood glucose of 28 mg/dL. She is unable to take anything by mouth. A family member administers intramuscular glucagon. Which of the following best explains how glucagon raises blood glucose in this setting?
Correct Answer
A — Glucagon stimulates hepatic glycogenolysis, mobilizing stored glycogen and releasing glucose into the circulation
Rationale
Glucagon acts on the liver to stimulate glycogenolysis — the breakdown of stored glycogen to glucose — rapidly raising blood glucose. This is why glucagon is effective for out-of-hospital treatment of severe hypoglycemia. It is ineffective in patients with depleted hepatic glycogen stores, such as those who have been fasting for extended periods or have significant liver disease. Glucagon does not stimulate beta cell insulin secretion, does not directly block glucose transporter type 4, and does not act on the intestine to increase glucose absorption.
Question 14
A woman with type 1 diabetes mellitus who is well-controlled on a fixed insulin regimen becomes pregnant. By the third trimester, her fasting glucose levels are consistently above target despite no change in her diet. Which of the following best explains why insulin requirements increase substantially during late pregnancy?
Correct Answer
C — Placental hormones — including human placental lactogen and progesterone — induce insulin resistance that progressively worsens through the third trimester
Rationale
Insulin requirements typically double by the third trimester of pregnancy due to placental hormone-driven insulin resistance. Hormones including human placental lactogen and progesterone antagonize insulin signaling at target tissues, requiring substantially higher insulin doses to achieve the same glucose-lowering effect. This insulin resistance resolves abruptly after delivery, and insulin requirements fall precipitously postpartum. Fetal pancreatic insulin does not cross-react with maternal receptors to cause downregulation. Renal clearance of insulin is not the driver of increased requirements in late pregnancy. Counter-regulatory hormone release from fetal glucose consumption is a minor contributor compared to placental hormonal insulin resistance.
Clinical Correlations · Questions 15–18
Apply pharmacological knowledge to clinical scenarios. Each vignette presents a patient situation; the question tests mechanism of action or drug selection.
Question 15
A 24-year-old man with type 1 diabetes mellitus is started on a basal-bolus insulin regimen consisting of insulin glargine once nightly and insulin lispro before each meal. His endocrinologist explains that the basal insulin component serves a specific physiological function between meals and overnight. Which of the following best describes the mechanism by which basal insulin achieves glucose control during fasting periods?
Correct Answer
B — Basal insulin suppresses hepatic glucose output by inhibiting gluconeogenesis and glycogenolysis between meals
Rationale
During fasting periods, the liver continuously releases glucose into the circulation through gluconeogenesis and glycogenolysis. Basal insulin suppresses this hepatic glucose output, preventing fasting hyperglycemia between meals and overnight. In type 1 diabetes mellitus, where endogenous insulin secretion is absent, unrestrained hepatic glucose output causes marked fasting hyperglycemia unless covered by a long-acting basal analog. Basal insulin does not stimulate glucagon, promote gastric emptying, or act on renal glucose reabsorption.
Question 16
A 32-year-old man with type 1 diabetes mellitus takes his usual evening insulin dose and then consumes several alcoholic beverages at a party. Approximately six hours later, he is found confused with a blood glucose of 38 mg/dL. Which of the following best explains why alcohol consumed in the evening caused hypoglycemia hours later?
Correct Answer
D — Alcohol inhibits hepatic gluconeogenesis, removing the liver's ability to raise blood glucose during the overnight fast
Rationale
Alcohol is metabolized in the liver and generates excess nicotinamide adenine dinucleotide, which inhibits gluconeogenesis by diverting gluconeogenic substrates away from glucose synthesis. When a patient who has taken insulin consumes alcohol, the liver loses its counter-regulatory capacity to raise glucose during the overnight fast, allowing insulin to drive blood glucose progressively lower over the following hours. This explains the delayed presentation — 4 to 8 hours after alcohol ingestion — rather than an acute postprandial effect. Alcohol neither stimulates insulin secretion nor alters insulin receptor binding or subcutaneous absorption rates.
Question 17
A 58-year-old man with type 2 diabetes mellitus is prescribed neutral protamine Hagedorn insulin injected at 10:00 PM. Three weeks later, he reports that he frequently wakes between 2:00 and 3:00 AM with sweating and palpitations; his blood glucose at those times is consistently below 60 mg/dL. His morning fasting glucose is normal. Which of the following best explains the mechanism of his nocturnal hypoglycemia?
Correct Answer
A — Neutral protamine Hagedorn insulin reaches its peak activity 4 to 8 hours after injection, coinciding with the overnight fasting period
Rationale
Neutral protamine Hagedorn insulin has a pronounced peak at 4 to 8 hours after injection. When injected at bedtime, this peak occurs during the 2:00 to 4:00 AM window — the deepest overnight fasting period, when no carbohydrate intake is present to offset the insulin effect. The resulting insulin surge drives blood glucose below the hypoglycemic threshold. Long-acting basal analogs such as glargine and degludec are designed to produce a flat, peakless profile and are preferred for bedtime dosing for this reason. Day-to-day variability in absorption is a known property of neutral protamine Hagedorn insulin; however, the consistent timing of hypoglycemia at 2:00 to 3:00 AM reflects the predictable peak of the preparation, which explains why switching to a peakless basal analog resolves this pattern.
Question 18
A 67-year-old man with type 2 diabetes mellitus undergoes major abdominal surgery and is admitted to the intensive care unit postoperatively. He is receiving nothing by mouth and requires insulin to maintain blood glucose between 140 and 180 mg/dL. Which of the following insulin preparations is most appropriate for intravenous infusion in this setting?
Correct Answer
C — Regular insulin
Rationale
Regular insulin is the only insulin preparation approved for intravenous administration. It is used for continuous intravenous infusion in the intensive care unit and perioperative setting, where precise titration of glucose control is required. Rapid-acting analogs such as insulin lispro are administered only subcutaneously. Insulin glargine is formulated at acidic pH for subcutaneous use and cannot be given intravenously. Neutral protamine Hagedorn insulin is a suspension formulated for subcutaneous injection.